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Abstract: Mounting evidence points to a role of the circadian clock in the temporal regulation
of post-transcriptional processes in mammals, including alternative splicing (AS). In this study,
we carried out a computational analysis of circadian and ultradian rhythms on the transcriptome
level to characterise the landscape of rhythmic AS events in published datasets covering 76 tissues
from mouse and olive baboon. Splicing-related genes with 24-h rhythmic expression patterns showed
a bimodal distribution of peak phases across tissues and species, indicating that they might be
controlled by the circadian clock. On the output level, we identified putative oscillating AS events
in murine microarray data and pairs of differentially rhythmic splice isoforms of the same gene in
baboon RNA-seq data that peaked at opposing times of the day and included oncogenes and tumour
suppressors. We further explored these findings using a new circadian RNA-seq dataset of human
colorectal cancer cell lines. Rhythmic isoform expression patterns differed between the primary
tumour and the metastatic cell line and were associated with cancer-related biological processes,
indicating a functional role of rhythmic AS that might be implicated in tumour progression. Our data
shows that rhythmic AS events are widespread across mammalian tissues and might contribute to a
temporal diversification of the proteome.
Keywords: circadian rhythms; ultradian rhythms; alternative splicing; splicing factors; splice isoforms;
cancer; tumour progression
1. Introduction
Alternative splicing (AS) describes the differential inclusion or exclusion of pre-mRNA regions into
protein-coding mRNA that affects approximately 95% of human multi-exon genes [1,2]. The production
of multiple protein isoforms with related, distinct and sometimes even antagonistic properties from
a single gene is a critical determinant of proteome diversification both on the spatial level, e.g., by
contributing to cell type and tissue specificity, and on the temporal level, e.g., in different developmental
stages [3]. Aberrant AS is associated with various human pathologies, including cancer, where splicing
switches are linked to several cancer hallmarks [4–7]. It has been suggested that the precise timing of
splicing is important for the dynamic control of AS decisions [8]. Moreover, 24-h transcriptional rhythms
of splicing-related genes and AS events have been identified in mammalian cells both in vivo [9] and
in vitro [10,11] and Titin isoform expression changes have been observed in the muscles of mice with a
skeletal muscle-specific knockout of the core circadian clock gene Arntl [12]. These findings suggest a
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circadian control of the splicing process [13] which might result in the time-dependent production of
functionally distinct protein isoforms of the same gene.
Cellular timing is regulated by the circadian clock, a self-sustained endogenous oscillator driven
by transcriptional and translational feedback loops that generate tissue-specific ~24-h rhythms in
the expression of clock-controlled genes and proteins [14]. Circadian rhythms in transcription
and—to a lesser extent—their higher-order harmonics, also known as ultradian rhythms, are prevalent
across mammalian tissues and cell lines [15–19]. However, so far, high-throughput transcriptome
circadian studies usually analyse oscillations on whole gene-level and do not consider the rhythmic
expression of individual splice isoforms, thus missing a potential additional layer of circadian
post-transcriptional regulation.
Here, we present a systematic genome-wide evaluation of circadian and ultradian rhythms in
transcription in the two most comprehensive circadian datasets of mammalian tissues available to
date: a microarray dataset of twelve mouse organs [15] and a recently published RNA-sequencing
(RNA-seq) dataset of 64 tissues and brain regions from the olive baboon [16]. Our analysis revealed
splicing-related genes with consistently circadian expression patterns across tissues and species in
mouse and baboon, as well as 24-h and 12-h rhythmic putative AS events in the murine microarray
data. We further developed a workflow for the identification and quantification of rhythmic isoform
changes in time-course RNA-seq data by comparing transcript-level oscillations of splice isoforms
encoded by the same gene. We identified pairs of differentially 24-h rhythmic isoforms in baboon
tissues whose expression patterns were shifted by several hours and peaked at opposing times of the
daily cycle. Functional annotation of candidate genes with phase-shifted isoforms suggests a reciprocal
interplay between circadian AS and the splicing process itself and revealed several oncogenes and
tumour suppressors among the candidate genes with rhythmic AS events in multiple baboon tissues.
To further explore these findings, we complemented our study with a novel RNA-seq dataset of
two human colorectal cancer (CRC) cell lines, SW480 and SW620, that were derived from the same
patient from a primary tumour and a metastasis, respectively, and that are known to display distinct
circadian phenotypes [10,20]. We identified differing sets of phase-shifted transcript pairs in both cell
lines, some of which were implicated in cancer-related biological processes. Overall, our findings
point to an additional temporal layer of proteome diversification in mammals via rhythmic AS that
results in the production of distinct splice isoforms expressed at different times and may account for a
time-dependent function of the resulting proteins.
2. Results
2.1. Rhythmicity Analysis of Mammalian Tissues Reveals Differences between 24-h and 12-h Rhythmic Features
at the Gene- and at the Transcript-Level
Circadian rhythms in transcription are ubiquitous in mammalian cells. To investigate whether
transcriptomic rhythmicity differs when analysed at the transcript rather than at the whole gene-level,
we identified oscillations of both transcripts and genes in an RNA-seq dataset of 64 tissues from the
olive baboon [16] and compared them to oscillating genes identified in a microarray dataset of twelve
mouse organs [15] (Figure 1A, Table S6). Both datasets include samples taken at discrete circadian
time points (every 2 h) for two circadian cycles (48 h) in the mouse and one circadian cycle (24 h) in
the baboon, resulting in a total of 1055 samples. While the mice were kept under a constant darkness
(DD) cycle after having been entrained to an 12 h light: 12 h dark (LD) cycle for a week) with sampling
starting 18 h post release into darkness, the baboons were kept under an LD cycle.
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Figure 1. Identification of 24-h and 12-h rhythmic features in nocturnal and diurnal ma malian tissues.
(A) Workflow of the analysis. The input data consists of three mammalian circadian transcriptome
datasets: a microarr y dataset of twelve murine tissues (GSE54650), an RNA-seq dataset of 64 olive
baboon tissues (GSE98965), and a novel RNA-seq dataset of two human CRC cell lines (E-MTAB-7779).
For the microarray data, gene-level expression values were calculated based on RMA-preprocessed
intensity values. For the RNA-seq data, sequencing reads were aligned to the transcriptome and both
transcript-level and summarised gene-level abundances were estimated. 12-h and 24-h rhythmic gene
and transcript sets were identified using RAIN. Candidate AS events in the microarray data were
identified using FIRMAGene and candidate differentially rhythmic isoforms in the RNA-seq data were
identified using DODR. (B) Number of 12-h (light blue) and 24-h rhythmic (dark blue) genes in twelve
murine tissues.
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(C) Number of genes (left panel) and gene types in percent (right panel) for the total sets of 12-h and
24-h rhythmic genes across all murine tissues and their intersection. (E) Number of 12-h (light blue)
and 24-h rhythmic (dark blue) genes (upper panel) and transcripts (lower panel) in 64 baboon tissues.
Each of the baboon tissue samples is represented according to the number of 24-h rhythmic transcripts
(y-axis) and the number of 24-h rhythmic genes (x-axis) (left panel) and to the number of 12-h rhythmic
transcripts (y-axis) and the number of 12-h rhythmic genes (x-axis) (right panel). (F) Number of genes
(left panel) and gene types in percent (right panel) for the total sets of 12-h and 24-h rhythmic genes
across all baboon tissues and their intersection.
A harmonic regression analysis revealed clusters of rhythmic genes for periods of circadian length
(~24 h) and for ultradian periods at the second harmonic of circadian rhythmicity (~12 h) (Figure S1).
For the mouse, we identified 9045 genes as 24-h rhythmic and 4140 genes as 12-h rhythmic (RAIN
q < 0.05 after pre-filtering of RAIN p-values for genes with relative amplitude ≥ 0.1) in at least one
tissue (Figure 1B). 2673 genes were detected as both 24-h and 12-h rhythmic, depending on the tissue
(Figure 1C). In the baboon dataset, we identified 14,881 genes as 24-h rhythmic and 8763 genes as 12-h
rhythmic (RAIN p < 0.005 and relative amplitude ≥ 0.1) in at least one tissue (Figure 1D,F). In agreement
with the observation for the murine tissues, most rhythmic baboon genes (82%) showed oscillations
with periods of both 24-h and 12-h, depending on the tissue (Figure 1F). Applying the same criteria for
the transcript-level counts, 21,379 transcripts were identified as 24-h rhythmic and 12,941 transcripts
as 12-h rhythmic in baboon tissues (Figure 1D), resulting in a roughly linear correlation between the
number of rhythmic genes and the number of rhythmic transcripts (Figure 1E).
When comparing the identity of the rhythmic genes identified either at the gene or at the
transcript-level for each baboon tissue, we observed that on average, the number of genes in the
intersection of the two gene sets was only 40% of the set union for the 24-h rhythmic genes and only 25%
of the set union for the 12-h rhythmic genes (Figure 2A,B). Interestingly, the tissue-wise median of RAIN
p-values of genes from the intersection (identified as rhythmic at both the gene and transcript-level)
was generally lower than that of the genes identified as rhythmic at gene-level only (Figure S2A).
While the phase distributions of rhythmic features in individual tissues were similar between both
the gene and the transcript-level (Figure S2B), both 24-h and 12-h rhythmic transcript sets tended to
have higher relative amplitudes than their counterparts at gene-level (Figure S2C). While across all
baboon tissues, an expressed gene had on average 1.7 expressed transcripts, some genes exhibited a
significantly higher number of expressed transcripts, the maximum being 18 for EPB41L2, RACK1,
and ENSPANG00000011737, a novel orthologous gene to murine gene Dhrs4 (Figure 2C). A similar
ratio was observed for the average number of expressed transcripts per rhythmic gene (24-h rhythmic:
1.80; 12-h rhythmic: 1.68), while the average number of rhythmic transcripts per rhythmic gene was
lower (24-h rhythmic: 0.71; 12-h rhythmic: 0.60), the maximum being five 24-h rhythmic transcripts
for MT3 and RACK1 (Figure 2D). For genes with several expressed transcripts, we further observed a
discrepancy between the expression pattern of the gene and the expression patterns of its individual
transcripts. For instance, the gene RABEP2 was identified as 24-h rhythmic in baboon stomach fundus
(STF) but its three expressed transcripts were not (Figure 2E). In contrast, two of the three expressed
transcripts of the gene TFG were identified as 24-h rhythmic in STF, albeit with different phases,
while the summarised expression of TFG at gene-level was arrhythmic (Figure 2F). In the first case,
the summarisation of transcript-level estimates to gene-level led to a gene being defined as rhythmic
despite the individual transcripts being arrhythmic, while in the second case, it led to a masking
of the (phase-shifted) rhythmicity of the individual transcripts. Hence, the rhythmicity analysis at
transcript-level is likely to yield new results that would be overlooked at gene-level.
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for more information on the compilation of the list). Of the expressed splicing-related genes, 38% and 
95% were detected to be either 12-h or 24-h rhythmic in at least one of the murine or baboon tissues, 
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subset of splicing-related genes to be consistently rhythmic across tissues. Thus, we focused on 
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Figure 2. Differences between the sets of genes identified as rhythmic on gene- and on transcript-level
in baboon tissues. Tissue-wise area-proportional Venn diagrams of the sets of genes that were identified
as (A) 24-h rhythmic and (B) 12-h rhythmic at gene-level (24-h rhythmic: dark blue; 12-h rhythmic:
light blue) and at transcript-level (dark grey) for the baboon data. The intersection of the two sets is
represented in light grey. (C) Frequency barplot of the number of expressed transcripts per expressed
genes in all baboon tissues. (D) Frequency barplots of the number of expressed transcripts per 24-h
rhythmic gene (dark blue, upper left panel) and per 12-h rhythmic gene (light blue, upper right panel),
and of the number of 24- r ythmic transcripts per 24- rhythmic ene (dark blue, lower left panel)
and of 12-h rhythmic transcri ts per 12-h rhythmic gene (light blue, lower right panel) in all baboon
tissues. (E) Example of ge (RABEP2) hat was de ect d to be 24-h rhythmic in baboon stomach
fundus (STF) at gene-level but not at transcript-level. (F) Example of a gene (TFG) that was detected to
be 24-h rhythmic in baboon STF at transcript-level but not at gene-level.
2.2. Splicing-Related Genes with 24-h Rhy hmic Expression Patterns are Conserved Across Mouse and Baboon
Tissues and Show Daily and Nightly Clusters of Peak Expression
The differential expression of multiple isoforms of the same gene can be attributed to AS of its
pre-mRNA, a process that is catalysed by the spliceosome and regulated by auxiliary splicing factors [21].
We examined the transcriptional expression and rhythmic parameters of 404 human splicing-related
genes that were mapped to 451 orthologous murine genes and to 429 baboon genes of which 409 and
408 were found to be expressed in at least one tissue, respectively (Table S2, see Section 4.5 for more
information on the compilation of the list). Of the expressed splicing-related genes, 38% and 95% were
detected to be either 12-h or 24-h rhythmic in at least one of the murine or baboon tissues, respectively.
Under the assumption t t AS is to some extent a rhythmic process, we would expect a subset of
splicing-related genes to b consistently rhythmic across tissues. Thus, we f cus d on splicing-related
genes that were identified as either 12-h or 24-h rhythmic in at least a quarter of the respective tissues
(Figure 3A,B). As expected, in both mouse and baboon, most of the splicing-related genes detected to
be rhythmic showed 24-h oscillations in transcription, whereas 12-h oscillations were an exception.
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The five most consistently rhythmic splicing-related genes in murine tissues comprised two members
of the hnRNP gene family, Cirbp and Fus, and three heat shock protein genes, Hspa1b, Hspa5, and Hspb1
(Figure 3A). In baboon, the five most consistently rhythmic splicing-related genes were HNRNPDL,
ENSPANG00000032278 (a novel orthologous gene to murine genes Hspa1a and Hspa1b), INTS1, RNF40,
and XAB2 (Figure 3B). In addition, we identified several splicing-related genes that were consistently
rhythmic in both mouse and baboon tissues, including Hspa1a/Hspa1b/ENSPANG00000032278, Hspb1,
Rbm45, and Srsf5.
Since the mere co-occurrence of rhythmicity does not necessarily indicate similar oscillatory
behaviour, we compared the peak phase and amplitude distributions (Figure 3C,D) and the expression
profiles (Figure S3A,B) of our set of candidate splicing-related genes. In terms of phase, we distinguish
between circadian time (CT) for mice kept under a DD cycle and zeitgeber time (ZT) for baboons
kept under an LD cycle. CT/ZT0 marks the beginning of the light phase and CT/ZT12 marks the
beginning of the dark phase. Overall, the peak phases of the individual genes were similar across
tissues (mean difference from the circular mean phase per gene: 0.97 h for the mouse and 1.33 h
for the baboon), with the exception of HSPA5 which showed antiphasic oscillations in digestive and
excretory baboon tissues compared to its expression patterns in baboon brain tissues (Figure S3B).
When comparing peak phases of orthologous splicing-related genes between the diurnal baboon and
the nocturnal mouse, we found most of them to be phase-shifted by about 12 h, as expected. In contrast,
Rbm45 and Cirbp were only shifted by about 3 h. To attain a broader view of the peak phase distribution
of the 24-h rhythmic splicing-related genes, we extended our candidate set to include all 83 genes that
were detected to be cycling with a circadian period in at least ten baboon tissues. For this larger set of
splicing-related genes, we identified a bimodal distribution of peak phases: The first cluster containing
about two thirds of the genes peaked during the subjective day (ZT6.1 ± 0.77) and the second cluster
containing about one third of the genes peaked during the subjective night (ZT18.6 ± 1.1) (Figure 3E),
indicating a possible control mechanism via components of the molecular clock. Since promoter
regions of clock-controlled genes are known to be GC-rich [22], we compared the GC content of the
promoter sequences (transcription start site (TSS) ± 1,000 bp) of the two clusters of consistently 24-h
rhythmic splicing-related genes with a set of the 18 arrhythmic splicing-related genes that were not
detected to be 24-h rhythmic in any baboon tissue. We found the promoters of the set of early peaking
splicing-related genes to be significantly more GC-rich than those of the arrhythmic splicing-related
genes (Wilcoxon p-value = 1.058 × 10−6) and the late-peaking splicing-related genes (Wilcoxon p-value
= 0.002101) (Figure 3F). We further tested for an enrichment of four potential clock transcription factor
binding sites (D-box, E-box, E’-box, and Rev response element (RRE)) in the promoter regions of the
two clusters of genes. We found the D-box motif to be significantly enriched for the set of early peaking
splicing-related genes (adj. p = 0.0298), indicating that the observed circadian changes of expression
might be due to a direct regulation via first-order clock-controlled transcription factors that bind to
D-boxes in a phase-specific manner, such as DBP and TEF [22]. In agreement with this, DBP and TEF
were among the top consistently circadian genes in baboon, identified to be 24-h rhythmic in 25 and 26
tissues, respectively, pointing to their potential contribution to the regulation of splicing processes by
binding to splicing-related genes. No enrichment for clock transcription factor binding sites was found
for the smaller set of late-peaking splicing-related genes, raising the possibility that they might instead
be regulated via other clock-controlled genes or through secondary circadian mechanisms.
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Figure 3. Consistent 24-h rhythmicity of splicing-related genes in mouse and baboon tissues.
Categorical heatmap for splicing-related genes that were detected as rhythmic (24-h rhythmic: dark
blue; 12-h rhythmic: light blue) in at least three of the murine tissues (A) and in at least 16 of the baboon
tissues (B). The respective upper panels represent the percentage of all rhythmic splicing-related genes
in the set of all rhythmic genes per tissue and the respective right panels represent the number of tissues
where the splicing-related genes were detected as rhythmic. Distribution of peak phases of selected
consistently 24-h rhythmic splicing-related genes and the core-clock components Arntl/ARNTL and
Per1/PER1 in the tissues from mouse (C) and baboon (D) in which they were detected as 24-h rhythmic.
Genes found to be consistently splicing in the respective organism are marked with an asterisk.
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(E) Circular boxplots of peak phases of splicing-related genes that were detected as 24-h rhythmic in at
least ten baboon tissues. (F) Promoter GC content in sets of arrhythmic, early peaking and late-peaking
24-h rhythmic splicing-related genes calculated for TSS ± 1,000 bp. Wilcoxon rank sum was used to
check for significant differences (n.s.: not significant, **: p < 0.01 ***: p < 0.001). Boxplots show (circular)
median and inter-quartile range (IQR). IQR is extended with whiskers to the largest and smallest value,
respectively, but no further than 1.5 × IQR from hinges.
2.3. Rhythmic AS Events are Prevalent in Murine Adipose and Muscle Tissues and are Found in Genes
Associated with the Circadian Clock
Following the hypothesis that the process of (alternative) splicing may be clock-regulated due to
the observed rhythmic expression of splicing-related genes, we would expect to find this rhythmicity
mirrored in AS events. While the design of whole-transcript microarray data does not allow for
the estimation of transcript-level expression, it can nevertheless be used to identify candidate genes
with rhythmic AS events, e.g., by applying the FIRMAGene method that scores potential splicing
events based on the persistence of probe-wise residuals from the robust multichip analysis (RMA)
fit [23] (Figure 4A). We were interested in identifying genes whose FIRMAGene score varied over time
according to a 24-h or 12-h rhythmic pattern, thus indicating a circadian or ultradian regulation of
AS. Overall, we identified 2,417 unique genes with 24-h rhythmic and 2,368 unique genes with 12-h
rhythmic candidate differential splicing events across all murine tissues (RAIN q < 0.1 and relative
amplitude ≥ 0.1) (Figure 4B and Table S3). Surprisingly, 12-h rhythmic splicing events not only made
up a large proportion of all identified rhythmic events in tissues with many 12-h rhythmic genes like
MUS (87%), and BAT (46%), but also in the heart (HEA, 97%) and liver (LIV, 49%) where only few 12-h
rhythmic genes had been previously identified (Figure 1B).
One of the candidate genes displaying a 12-h rhythmic FIRMAGene score in BAT was the type
2 diabetes-associated gene Capn10 which encodes for eight known protein isoforms in humans and
has been reported as a target of the splicing factor ZRANB2 [24,25]. Interestingly, Zranb2 showed a
12-h rhythmic expression pattern in BAT, indicating that its transcriptional oscillations might indeed
be propagated to the level of post-transcriptional regulation of one of its target genes (Figure S4D).
In adipose tissues, as well as in LIV and lung (LUN), the 24-h rhythmic FIRMAGene scores peaked
predominantly at the transition from the light to the dark phase, while in muscle tissues, they peaked
in the middle of the subjective day, and in the hypothalamus, in the middle of the subjective night
(Figure 4C and Figure S4C). For several genes, rhythmic FIRMAGene scores were identified in more than
one tissue, including splicing-related genes such as Hnrnpa1, splicing factor gene Mbnl2, the core-clock
genes Arntl2 and Nr1d1, and the clock-controlled gene Ciart (Figure S4A). Notably, the set of genes
with 12-h rhythmic FIRMAGene scores in more than one tissue also included several components of
the core-clock and clock-controlled genes, such as Arntl, Nr1d2, Npas2, and Dbp (Figure S4B). A Gene
Ontology (GO) enrichment analysis of the set of candidate genes with 24-h rhythmic FIRMAGene
scores revealed several metabolic processes to be among the significantly enriched biological processes
(q < 0.05), including steroid metabolic processes and sterol homeostasis, as well as the regulation of
intracellular transport (Figure 4D and Table S4). Interestingly, candidate genes with 12-h rhythmic
FIRMAGene scores were found to be enriched for, i. a., cold-induced and adaptive thermogenesis
(Figure 4D), possibly indicating an ultradian control of thermoregulation via rhythmic AS events.
Overall, these findings suggest that oscillating putative AS events with 24-h and 12-h periods are
widespread across murine tissues, supporting the hypothesis of a rhythmic regulation of splicing.
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Figure 4. Analysis of whole-transcript microarray data reveals candidate genes with 24-h and 12-h
rhythmic AS events in murine tissues. ( ) Schematic representation of the FIRMAGene analysis to
identify candidate g n s with rhythmic ents in the murine microarr y dataset. FIRMAGene uses
the RMA model to decompose probe-level microar ay dat be effects and expression l vels and
calculates probe-wise residuals from the RMA fit. Based on the assumption that several adjacent poorly
fitting probes for the same exon region that behave differently from the rest (residuals away from zero
and in the same direction) can be evidence of potential AS, the algorithm scores the persistence of
residuals from the RMA fit, yielding gene-level FIRMAGene scores for each individual time point.
(B) Number of genes with 24-h rhythmic (dark blue) and 12-h (light blue) candidate AS events in
the twelve murine tissues. (C) RAIN phase-sorted heatmaps of 24-h rhythmic (left panel) and 12-h
rhythmic (right panel) FIRMAGene scores in murine brown fat (BAT). (D) Enriched GO terms (Biological
Process−BP) for the sets of genes with 24-h rhythmic (upper panel) and 12-h rhythmic (lower panel)
candidate AS events in the murine tissues. For genes with 12-h rhythmic AS events, only the first ten
GO terms are shown. The complete lists of results can be found in Table S4.
2.4. Differential 24-h Rhythmic Isoform Pairs in Baboon are Phase-Shifted Across the Daily Cycle
Given the differences found between rhythmic features at gene- and at transcript-level in baboon
(Figure 2), the consistently 24-h rhythmic expression of splicing-related genes in both mouse and
baboon (Figure 3), and the observed rhythmicity of putative AS events in mouse (Figure 4), we used
the transcript-level baboon RNA-seq data to directly search for isoforms of the same gene that show
phase-shifted rhythmic expression patterns. To detect cases of differential rhythmicity of transcripts,
we applied the DODR method which tests for amplitude and phase changes between two conditions
of one rhythmic feature [26]. In particular, we compared each rhythmic transcript (RAIN p < 0.005
and relative amplitude ≥ 0.1) to all other rhythmic transcripts (RAIN p < 0.05 and relative amplitude
≥ 0.1) of the same gene with the same period in the same tissue in a pairwise manner (Figure 5A).
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Taking all tissues together, we obtained 16,120 pairs of 24-h rhythmic and 2576 pairs of 12-h rhythmic
transcripts of which 4546 pairs (2,096 genes) and 888 pairs (741 genes) were differentially rhythmic
(DODR q < 0.05), respectively. On average, a candidate gene with differentially rhythmic transcripts
was detected in 1.9 tissues for 24-h rhythmic isoform pairs and in 1.1 tissues for 12-h rhythmic isoform
pairs (Figure S5A). Differential rhythmicity can be due to changes in either amplitude or phase of the
rhythmic features, or both. We were particularly interested in identifying rhythmic transcripts pairs
with pure phase shifts in the same tissue, hypothesising that they might represent functionally distinct
splice isoforms of the same gene that are expressed at different times of the day. Hence, we filtered
for isoform pairs with an amplitude ratio smaller than 2 that were phase-shifted by at least a sixth of
their period length, resulting in a total of 1495 (1201 unique isoform pairs, 969 unique genes) and 320
(313 unique isoform pairs, 289 unique genes) phase-shifted isoform pairs with 24-h and 12-h rhythmic
expression patterns, respectively (Figure 5B,C and Table S5).
An analysis of the phase distribution and the phase difference of all phase-shifted 24-h rhythmic
isoform pairs revealed two clusters of transcripts that exhibited a phase-shift greater than 10 h and that
showed two peaks of expression between ZT 4–10 and between ZT 15–21 (Figure S5B). We further
compared the relations between the two peak times of a phase-shifted isoform pair and found that the
majority of 24-h rhythmic phase-shifted transcripts were indeed expressed at opposing times of the
daily cycle, with one transcript peaking in the middle of the subjective day and the other in the middle
of the subjective night (Figure 5D). For the set of 12-h rhythmic phase-shifted isoform pairs, the peak
times were distributed over the 12-h ultradian cycle, with most transcripts exhibiting phase-shifts
greater than 4 h (Figure S5B and Figure 5D).
A GO enrichment analysis of the whole set of candidate genes with 24-h rhythmic phase-shifted
isoforms revealed RNA processing, RNA splicing, Golgi vesicle transport, the regulation of mRNA
metabolic processes, and RNA localisation to be among the significantly enriched biological processes
(q < 0.05) (Figure 5E and Figure S5C and Table S4). Interestingly, Golgi vesicle transport was also
found to be enriched for the set of candidate genes with 12-h rhythmic phase-shifted isoforms
(p < 0.05) (Figure 5E). The prevalence of RNA splicing among the enriched processes hints at a
reciprocal regulation between the observed circadian rhythmicity of genes encoding for spliceosome
components and splicing factors and the tissue-spanning production of phase-shifted 24-h rhythmic
isoforms of genes involved in the splicing process. Several candidate genes displayed 24-h rhythmic
phase-shifted isoform pairs in multiple tissues, including the splicing factor gene PCBP2 (eight tissues),
the RNA binding protein gene NELFE (seven tissues), CIRBP (six tissues), and the scaffold protein
gene RACK1 (five tissues) (Figure S5C,D). Interestingly, both PCBP2 and NELFE have been identified
as oncogenes [27,28]. CIRBP is known as a mediator of cancer-related inflammation and has been
reported to act both as a tumour suppressor and a tumour promoter, depending on the cell type and
cancer stage [29], while RACK1 plays an important role in the regulation of key signalling pathways in
cancer [30]. In addition to the gene-level GO enrichment analysis, we searched for experimentally
validated functionally distinct splice isoforms (FDSIs) in healthy tissues [31] among our list of candidate
differentially rhythmic splice isoforms. Of the 23 human genes with FDSIs meeting the criteria of
Bhuiyan and colleagues, we found ten orthologous olive baboon genes with differentially 24-h rhythmic
isoform pairs in at least one tissue (CFLAR, EIF4G1 and EIF4G2, KLF6, MADD, MST1R, PML, PRMT5,
STIM2, and SUN1). Of these, the eukaryotic initiation factor gene EIF4G2, the splicing regulator gene
PRMT5, and the tumour suppressor genes KLF6 and PML had purely phase-shifted isoform pairs.
Thus, our findings regarding phase-shifted differentially rhythmic splice isoforms identified in
a variety of baboon tissues suggest a time-of-day dependent regulation of mRNA splicing through
alternative transcript usage of, i. a., splicing-related genes.
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Figure 5. Prevalenc of phase-shifted differenti ll -h and 12-h rhythmic splice isoforms in olive
baboon tissue . (A) Schematic representatio alysis of diff rentially r ythmic isoform pairs
in RNA-seq data. The rhythmic patter f ll xpre sed and rhythmic (with the same period)
transcripts of the same gene in the same tissue are co pared in a pairwise manner using the robust
DODR method in order to identify differentially rhythmic isoform pairs with a phase shift in peak
expression. (B) Amplitude ratio and phase difference of isoform pairs found to be differentially rhythmic
(DODR q < 0.05) with a period of 24 h (left panel) and 12 h (right panel). Phase-shifted isoform pairs
(amplitude ratio < 2 and phase-shift ≥ period/6) are marked by a black rectangle. (C) Number of 24-h
(dark blue) and 12-h rhythmic (light blue) phase-shifted isoform pairs in the 64 baboon tissues.
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(D) Chord diagrams representing the relations between the two peak phases of expression of 24-h
rhythmic (left panel) and 12-h rhythmic phase-shifted isoform pairs (right panel). Peak-phases are
clustered in bins of 3 h (left panel) and 2 h (right panel) and coloured according to the type of baboon
tissue in which they were detected. (E) Enriched GO terms (Biological Process—BP) for the sets of
genes that exhibited 24-h rhythmic (left panel) and 12-h rhythmic phase-shifted isoform pairs in the
baboon tissues. For visualisation, GO terms were manually curated to remove redundant categories.
The complete lists of results can be found in Table S4.
2.5. Genes with Phase-Shifted Splice Isoforms in a Human Cell Line Model of Colorectal Cancer Progression are
Enriched for mRNA Splicing and Have a Putative Impact on Cell Survival and Migration
Deregulations in splicing are often implicated in human disease, including cancer where frequent
alterations in splicing events and mutations in splicing factor genes have been reported [4,32–34].
Interestingly, several of our candidate genes with phase-shifted isoform pairs in multiple baboon
tissues were oncogenes and tumour suppressors. Thus, to investigate whether the rhythmic regulation
of isoform expression observed in normal mammalian tissues would be affected in tumorigenesis,
we profiled the circadian transcriptome of two human CRC cell lines by RNA-seq and estimated
gene- and transcript-level expression values as previously described (Figure 1A). We chose cell lines
derived from a primary carcinoma (SW480) and a lymph node metastasis (SW620) of the same patient
known to have different clock phenotypes [20] as a model system. Overall, we found 1343 24-h
rhythmic genes and 6,003 24-h rhythmic transcripts in SW480 cells and 1934 24-h rhythmic genes
and 5,395 24-h rhythmic transcripts in SW620 cells (RAIN p < 0.05 and relative amplitude ≥ 0.1)
(Figure S6A). As previously observed in mouse and baboon tissues, 12-h rhythms in transcription
were less prevalent (Figure S6A). Interestingly, the ratio of rhythmic transcripts to rhythmic genes
was higher for SW480 for both tested periods, indicating that despite the higher number of genes
detected as rhythmic in SW620, the number of individual oscillating isoforms was higher in the primary
tumour cell line (Figure 6A). In both SW480 and SW620 cells, splicing-related genes displayed 24-h
rhythms in expression that were specific for the respective cell line except for the cycling dependent
kinase gene CDK11A that was identified as oscillating for both (Figure S6B). In SW480, a bimodal
distribution of peak phases was observed in line with our findings in baboon tissues (Figure 6B).
However, when comparing the phases of individual splicing-related genes to those of their orthologous
baboon genes (SRSF5, SNRNP79, SRRT, and U2AF in SW480 and DDX39A, NOSIP, NUMA1, PQBP1,
SF3B3, SNU13, and TNPO1 in SW620), the phases of the human genes did not cluster in the same way
as the baboon genes did (Figure 6B). This could be due to differences between tissues or result from
alterations in clock-controlled transcription associated with tumour progression.
We further detected 253 and 83 phase-shifted 24-h rhythmic pairs and 36 and 26 phase-shifted
differentially 12-h rhythmic pairs for SW480 and SW620 cells, respectively (Figure 6C and Figure S6C
and Table S6). Given the small size of the 12-h rhythmic sets, we only conducted the subsequent
analyses for the set of 24-h rhythmic phase shifted isoforms. In SW480 cells, 30% of the phase shifted
isoform pairs consisted of a protein coding transcript and a transcript with a retained intron, followed
by pairs of two protein-coding transcripts (19.8%), pairs of two transcripts with retained introns (12.6%),
and pairs of a transcript with a retained intron and a nonsense-mediated decay (NMD) transcript
(12.3%) (Figure 6D). In SW620 cells, the largest set were pairs of two protein-coding transcripts (42%),
followed by pairs consisting of a protein-coding transcript and a transcript with a retained intron
(21.7%) (Figure 6D).
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Figure 6. Phase-shifted splice isoforms in human CRC cell ines. ( io f 2-h rhythmic (upper panel)
and 24-h rhythmic (lower panel) transcripts and genes for SW480 (blue) and SW620 (orange) for different
RAIN p-value cut-off levels. (B) Distribution of peak phases of 24-h rhythmic splicing-related genes
in the CRC cell lines SW480 (left upper panel) and SW620 (right upper panel) and their respective
orthologous genes in the baboon tissues (lower panels). Splicing-related genes that were either
shared between both cell lines or for which 24-h rhythmic orthologous baboon genes were identified,
are labelled by name. The grey area represents the subjective night from ZT12 to ZT24 (C) Number of
12-h (upper panel) and 24-h rhythmic (lower panel) differentially rhythmic isoform pairs in the CRC
cell lines. The proportion of phase-shifted isoform pairs is marked in grey. (D) Transcript biotypes of
24-h phase-shifted isoform pairs in percent (left panel) and chord diagrams representing the types of
isoform pairs for SW480 (middle panel) and SW620 (right panel).
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(E) Phase distribution and pairwise phase-difference of phase-shifted differentially 24-h rhythmic
isoform pairs in SW480 cells (upper panel, blue) and SW620 cells (lower panel, orange). (F) Expression
(log2 CPM) of the transcripts ANKHD1-205 and -210 (upper left panel) and MYO1C-202 and -203
(lower left panel) in SW480 (blue) and SW620 (orange) and visualisation of the genomic structure of
ANKHD1 (upper right panel) and MYO1C transcripts (lower right panel). Differences in the exonic
composition are marked with red rectangles.
In SW480 cells, we detected a peak of expression for transcripts with phase-shifted isoform pairs at
~16.5 h, whereas the distribution for SW620 cells was bimodal, with peaks at ~5 h and ~15 h (Figure 6E).
A GO analysis revealed that the genes with phase-shifted isoform pairs were enriched for, i. a.,
lipoprotein-related processes, as well as for cytokinesis and the negative regulation of RNA splicing in
SW480 cell lines, and for (alternative) RNA splicing, post-transcriptional regulation of gene-expression,
and the regulation of translation in SW620 cells (Figure S6E and Table S4). The prevalence of
splicing-related processes for both cell lines mirrors the results of the enrichment analysis for the
baboon tissues and is in line with results from previous studies that have reported extensive AS of
splicing-related genes in cancer [35,36]. 16 genes from the list of splicing-related genes (Table S2) were
found among the candidates in SW480 cells (CLK4, DDX3X, GRSF1, HNRNPK, HNRNPL, INTS6L,
MOV10, NONO, NXF1, PCBP2, RBM3, RBM39, SRRT, TAF15, U2AF, ZNF131) and eight genes were
found in SW620 cells (CCAR2, CELF1, CIRBP, DDX17, HNRNPC, PABPC1, RBM4, SRSF2) (Figure S6D).
Only three of the splicing-related candidate genes in SW480 (RBM39, SRRT, and U2AF2) and none in
SW620 had previously been found to be oscillating at gene-level (Figure S6B), indicating that their
transcript-level rhythmic expression was masked due to the phase-shifted expression of their individual
transcripts. Except for CCAR2, CELF1, and RBM4, not all transcripts pairs of splicing-related genes
were annotated to be protein-coding which makes it unclear whether the observed rhythmic AS has a
functional effect on cellular physiology or whether it is unproductive.
In light of our previous findings and the known importance of AS events in carcinogenesis and
tumour-progression, we checked for cancer-related splice isoforms among our candidate genes for
which both transcripts were annotated as protein-coding, such as ANKHD1 in SW480 and MYO1C
in SW620 (Figure 6F). ANKHD1 is an ankyrin repeat and KH domain-containing protein for which
two functional AS variants have been characterised: In contrast to the canonical isoform, VBARP-L
(11 exons) and VBARP-S (9 exons) both contain only a single ankyrin repeat motif and lack the signature
KH domain. [37]. The 24-h rhythmic transcript ANKHD1-205 in SW480 encodes for VBARP-L, whereas
the ~10.5 h phase-shifted transcript ANKHD1-210 consists of eight exons that encode for the KH
domain and do not overlap with the exons of ANKHD1-205 (Figure 6F). MYO1C is a member of the
unconventional myosin gene family and produces three AS isoforms through N-terminal splicing
which differ in their functions and their nucleo-cytoplasmic partitioning [38]. The 24-h rhythmic
transcript MYO1C-202 in SW620 encodes for the isoform MYO1CC which localises predominantly to
the plasma-membrane and is involved in cell migration and signal transduction, whereas the ~7.4 h
phase-shifted transcript MYO1C-203 encodes for the isoform MYO1CB, also known as nuclear myosin
I (NMI) or MYO1C16 which localises mostly to the nucleus where it is involved in transcription, mRNA
maturation, and chromatin remodelling [38] (Figure 6F). Notably, the expression patterns of ANKHD1
and MYO1C transcripts differ between the cell lines (Figure 6F), indicating that they are indeed specific
for different stages of tumour progression. Altogether, our findings concerning oncogenes and tumour
suppressor genes among the candidates with putative rhythmic AS events in healthy baboon tissues
are reinforced by the results of the analysis in the human CRC progression model, uncovering potential
cancer-relevant rhythmically expressed isoforms.
3. Discussion
AS is an essential pre-mRNA processing mechanism that enables the functional diversification of
the proteome via the production of several distinct protein isoforms from a single gene. In this study,
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we aimed to elucidate whether the process of AS might be temporally regulated over the course of the
day at the organismal level, potentially leading to rhythmic expression patterns of individual splice
isoforms. For this purpose, we developed a workflow for the genome-wide identification of AS events
in circadian whole-transcript microarray data and the detection of differentially rhythmic isoforms of
the same gene in circadian RNA-seq data (Figure 1A). Using the most comprehensive mammalian
circadian dataset of a diurnal primate currently available, we compared the number and the rhythmic
properties of 24-h and 12-h rhythmic features identified either at gene- or at transcript-level in 64
tissues from the olive baboon. In addition to the prevalence of 24-h transcriptional rhythmicity in
mammalian tissues, the existence of higher-order harmonics of circadian gene expression has been
shown for mouse liver in vivo [17], and recently also for murine fibroblast cells in vitro [19]. Hence,
we also tested for ultradian rhythms with a 12-h period. We found that while the correlation between
the number of rhythmic genes and the number of rhythmic transcripts was roughly linear, the identity
of rhythmic genes differed depending on whether the input expression data was based on individual
transcript counts or on summarised gene counts. We further observed that some genes were classified
as rhythmic even though their individual transcripts were arrhythmic. Conversely, some genes
were not defined as rhythmic, despite having oscillatory transcripts that displayed phase-shifted
patterns. Interestingly, the sets of rhythmic transcripts displayed higher amplitudes than the sets of
rhythmic genes; moreover, features identified as rhythmic on both transcript- and gene-level had lower
p-values in the rhythmicity analysis than features identified only on gene-level. Thus, our results
demonstrate that a transcript-level rhythmicity analysis might on the one hand potentially contribute
to the improvement of rhythm detection on gene-level and on the other hand yield novel results
concerning oscillating splice isoforms which would otherwise be overlooked.
Splicing-related genes have previously been found to oscillate with circadian expression patterns
in murine liver [9] and human colorectal cancer cell lines [10]. In the present study, we identified a set
of more than 80 consistently 24-h rhythmic splicing-related genes in baboon tissues that displayed
a bimodal distribution of peak phases with two thirds of the genes peaking during the subjective
daytime (early genes) and one third of the genes peaking during subjective nighttime (late genes).
Our findings are in line with the results of McGlincy and colleagues who also identified two clusters of
peak phases during the subjective day and night [9]. We further found evidence for a possible clock
regulation of the set of early-peaking splicing-related genes whose promoter regions were significantly
more GC-rich than those of late-peaking and arrhythmic splicing-related genes. They were also
enriched for the D-box motif, a potential clock transcription factor binding site [39]. GC-rich motifs
have been found to be overrepresented in promoter regions of clock-controlled genes [22]; hence,
our results point to a possible regulation of the early-peaking splicing-related genes via first-order
D-box binding clock-controlled transcription factors such as DBP and TEF [39]. According to the
TRANSFAC database of eukaryotic transcription factors and their genomic binding sites, both the
early-peaking gene DHX30 and the late-peaking gene SYNCRIP are targets of DBP [40,41]. Several of
the consistently 24-h rhythmic splicing-related genes were also found to oscillate in murine tissues
with approximately 12-h phase shifts when compared to the baboon: the hnRNP coding gene Fus and
the splicing factor gene Srsf5, both of which peak during the active phases of the animals, and the
heat shock protein gene Hspb1 that peaks in the rest phase. Fus is a neurodegeneration-associated
protein that binds to distinct RNA sites of its target genes to regulate the inclusion of alternative exons
and that has recently been found to be transcriptionally regulated by core-clock component Nr1d1
and to modulate the expression of core-clock genes Per2 and Cry1 [42,43]. In contrast, both Hspb1 and
Srsf5 have been reported to be regulated via temperature variations: While Hspb1 expression has
been associated with the efficiency of splicing recovery after heat shock [44], transcript and protein
levels of the splicing factor Srsf5 have been shown to be cold-inducible in mammalian cells cultured at
32 ◦C [45]. Interestingly, the cold-inducible splicing factor SRSF5 also displayed 24-h rhythmic patterns
in transcription in human SW480 cells kept under constant conditions, indicating that its oscillations
are not solely due to changes in the internal body temperature of animals. A notable exception to the
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expected ~12-h shift between oscillations in a diurnal and a nocturnal animal was the cold-inducible
hnRNP encoding gene Cirbp: In mouse, Cirbp peaks in the middle of the subjective day, coinciding
with a trough in the core body temperature of male C57Bl/6 mice [46], supporting the hypothesis
of a temperature-dependent control of Cirbp [47,48]. Yet, the morning peak of expression of CIRBP
at ~ZT3 in baboon overlapped with the time at which the body temperature of the animals reached
its peak (~37.8 ◦C) [16], indicating that Cirbp control mechanisms might differ between diurnal and
nocturnal mammals. It has to be noted that in vivo, 24-h rhythms in transcription may be due to direct
circadian regulation via components of the molecular circadian clock or clock-controlled transcription
factors, or due to secondary circadian effects, such as diurnal changes in body temperature [49] or
cortisol levels [50]. For instance, AS of the splicing factor gene U2af26 has been shown to be temporally
controlled via temperature changes [51] and the cortisol-inducible splicing factor SRSF3 promotes the
splicing of human glucocorticoid isoform GRα which transcriptionally regulates RACK1 by binding to
its promoter [52].
Under the assumption that the 24-h rhythmic expression patterns of trans-acting splicing-related
genes might be propagated to the transcriptional output of their target genes, we looked for evidence of
rhythmic splicing events on a genome-wide level for two mammalian model organisms, the nocturnal
mouse and the diurnal baboon. Taking into account the technical design of the circadian whole-transcript
array data from mouse, we found candidate genes with putative rhythmic AS events with either
24-h or 12-h periods to be prevalent in adipose and muscle murine tissues. Interestingly, many of
the candidate genes with rhythmic AS events identified in multiple tissues were associated with the
circadian clock. While the study by Zhang and colleagues [15] also contains 48-h time-series RNA-seq
data for the same murine organs, the sampling resolution of 6 h (instead of 2 h for the microarrays)
does not suffice to identify 12-h or 24-h rhythmic features with confidence and thus could not be used
for the purpose of our study.
Remarkably, our transcript-level analysis of the baboon RNA-seq data revealed a wide array
of differentially 24-h rhythmic transcripts of the same gene whose oscillatory expression patterns
displayed similar amplitudes but peaked at opposing times of the daily cycle, indicating a rhythmic
control of AS events. This genome-wide distribution of daily and nightly isoform peaks suggests a
possible distinct functional role of the involved transcripts that might depend on their expression level
at a specific time-of-day. At gene-level, phase-shifted isoform pairs were found to be significantly
enriched for RNA processing and mRNA splicing processes. This suggests a reciprocal interplay
between the observed circadian expression patterns of splicing-related genes on the one hand and the
time-of-day-dependent production of splice isoforms on the other hand. In addition, Golgi vesicle
transport was found to be enriched for both the set of candidate genes with 24-h and with 12-h rhythmic
phase-shifted isoforms, suggesting a complex temporal regulation of the secretory pathway that may
possibly be regulated via circadian and ultradian splice isoform production. AS events have recently
been shown to affect the secretory pathway [53] and a circadian control of procollagen transport from
ER-to-Golgi and Golgi-to-plasma membrane has been reported in mice [54]. Among the genes with
24-h rhythmic phase-shifted isoform pairs in multiple baboon tissues, we identified several oncogenes
and cancer-related genes, including PCBP2, NELFE, CIRBP, and RACK1. We further compared our
candidate rhythmically spliced baboon genes to a list of genes with known functionally distinct
isoforms that have been experimentally validated in human. Of these, the genes EIF4G2, PRMT5,
and the tumour suppressor genes PML and KLF6 expressed phase-shifted isoform pairs in baboon
tissues. Interestingly, AS of human KLF6 results in the dominant negative splice isoform KLF6-SV1,
which has been identified as a key driver of breast cancer and prostate cancer metastasis by promoting
cell survival, migration, and invasion [55,56]. However, it still remains to be elucidated whether the
specific isoforms and their function are conserved between human and baboon.
In view of the known significance of alternatively spliced isoforms in cancer and tumour
progression [32,33] which is further reinforced by our discovery of oncogenes and tumour suppressors
among the candidate rhythmically spliced genes, we extended our study by including a novel RNA-seq
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dataset of human CRC cell lines SW480 (primary tumour) and SW620 (metastasis) that originate
from the same patient. Both SW480 and SW620 cells displayed 24-h rhythms in transcription of
splicing-related genes as well as phase-shifted isoform pairs that were largely specific for the respective
cell line. As previously observed in baboon, the genes with 24-h rhythmic phase-shifted isoform pairs
were enriched for splicing processes and included various splicing-related genes, e.g., NONO and
PCBP2 in SW480 and CELF1 and CIRBP in SW620 cells. NONO, PCBP2, and CIRBP also displayed
phase-shifted isoforms in multiple baboon tissues, indicating that rhythmic AS of these genes might
not only be conserved across tissues but also across different mammalian species. The transcription
factor NONO is known to bind to the core-clock protein PER and to antagonise its activity [57] and has
furthermore been reported to act as a coupling element between the circadian clock and the cell cycle [58].
CELF1 has been reported to promote the expression of pro-tumourigenic genes and to be a critical
regulator of cancer biological processes, such as proliferation, cell survival, and epithelial-mesenchymal
transition (EMT) [59,60]. In line with these findings, several of the phase-shifted protein-coding
transcripts in the CRC cell lines, e.g., ANKHD1 and MYO1C transcripts, were found to be associated
with cancer-related biological processes such as cell survival and migration, hinting at a possible role of
rhythmic AS in CRC tumour progression. ANKHD1 is overexpressed in acute leukaemia [61] and its
VBARP isoforms have been reported to have an antiapoptotic effect and to play a role in cell survival
pathways [37]. MYO1CA, an isoform of MYO1C, is involved in prostate cancer cell migration [62] and
it has been speculated that alterations of MYO1C at the plasma membrane might affect the metastatic
potential of tumour cells [63]. Thus, it is conceivable that a temporal regulation of functionally distinct
isoforms might enable CRC cells to produce protein isoforms at specific times of the day that facilitate
their malignant transformation.
In summary, circadian splicing-related genes and rhythmic AS events with a 24-h period (and to
a lesser extent a 12-h period) appear to be widespread across mammalian tissues, supporting the
hypothesis of a circadian regulation of the splicing process. Several of the candidate differentially
spliced genes encode for functionally distinct protein isoforms that might influence cellular processes in
a time-of-day-dependent manner. Nonetheless, further experimental datasets with a higher coverage
and/or longer reads and containing a sufficient number of replicates per condition (which are usually
not part of the design of high-throughput circadian transcriptome studies [64]) will be necessary for the
subsequent exploration of our results. We partially mitigated this problem by focusing on candidate
genes for which phase-shifted isoform pairs could be found in more than one tissue, thus strengthening
our confidence in the putative circadian AS event. However, AS is known to be tissue-specific [3],
a fact that is likely also true for circadian AS [9]. Thus, the experimental design of future studies on
rare tissue-specific rhythmic AS events should implement further measures for the accurate detection
of alternative splice isoforms, either by including additional time point replicates or by increasing
coverage and/or RNA-seq read length. Moreover, information about the functional impact of specific
isoforms is still sparse to date [65], especially for less-extensively studied model organisms such as the
olive baboon, thus preventing a functional annotation at transcript-level. Future experimental studies
that aim at targeted isoform depletion of a phase-shifted transcript pair might yield more information
concerning the functional effect of rhythmic AS and ascertain whether the affected splice isoforms
are indeed functionally relevant and thus contribute to the postulated diversity of the proteome.
Nonetheless, our systems-level analysis across different tissues and organisms provides compelling
evidence for rhythmic AS and its potential role in the temporal diversification of the mammalian
proteome. Thus, it is conceivable that diverse splice isoforms expressed at different times of the day
will lead to a time-dependent function of proteins and that failures in this temporal control may impact
on the normal regulation of cellular processes and ultimately drive malignancy.
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4. Materials and Methods
4.1. Cell Culture
Human colorectal carcinoma cell lines SW480 and SW620 were purchased from the ATCC.
Cells were maintained in DMEM low glucose (Lonza, Walkersville, MD, USA) culture medium
supplemented with 10% FBS (Life technologies, Inc., Wilmington, DE, USA), 1% penicillin-streptomycin
(Life technologies, Inc., Wilmington, DE, USA), 1% HEPES (Life technologies, Inc., Wilmington,
DE, USA) and 2 mM Ultraglutamine (Lonza, Walkersville, MD, USA) at 37 ◦C in a humidified
atmosphere with 5% CO2.
4.2. Sample Preparation
SW480 and SW620 cells were seeded in triplicates in 6-well plates with a density of 1–2 × 106 cells
one day prior to the experiment. On the next day, cells were synchronised by changing the medium.
Sampling was started 12 h after synchronisation and samples were taken every 3 h for a time-series of
30 h and prepared for RNA extraction. Total RNA was isolated using the RNeasy Mini Kit (Qiagen,
Valencia, CA, USA) including 15 min DNase I digestion according to the manufacturer’s instructions.
Prior to the purification procedure, medium was discarded and cells were washed twice with PBS
and lyzed in RLT buffer (Qiagen, Valencia, CA, USA). RNA was eluted in 30–50 µL RNase-free water.
The final RNA concentration was determined with a NanoDrop 1000 spectrophotometer (Thermo Fisher
Scientific, Wilmington, DE, USA). RNA was stored at −80 ◦C until use. mRNA libraries were generated
from high quality RNA (average RNA quality number (RQN) of 10.0) and prepared using the TruSeq
Stranded mRNA Sample Preparation Kit (Illumina, San Diego, CA, USA) according to the low sample
protocol guidelines and sequenced on an Illumina NextSeq 500 platform to an average depth of 74
M (min. 49 M, max. 129 M) 75 bp paired-end reads at the European Molecular Biology Laboratory
(EMBL) GeneCore Facility (EMBL, Heidelberg, DE).
4.3. Processing Microarray and RNA-Seq Transcriptome Data
For the murine microarray dataset (GSE54650), raw expression data was downloaded from the
Gene Expression Omnibus (GEO) database and preprocessed using the Robust Multichip Average
(RMA) [66,67] function from the oligo R package version 1.42.0 [68]. Transcript clusters were
annotated using Affymetrix mogene10 annotation data (https://bioconductor.org/packages/release/
data/annotation/html/mogene10sttranscriptcluster.db.html, version 8.7.0). For the human CRC cell lines
RNA-seq dataset, quality control was performed using FastQC version 0.11.7 [69] and residual adapter
sequences were trimmed from the reads using Trimmotatic version 0.38 [70] with TruSeq3-PE-2.fa
adapter sequences (default parameters). Only paired-end reads were retained for the downstream
analyses. Raw data have been deposited in the EBI’s ArrayExpress database under the accession
number E-MTAB-7779.
Single-end sequencing reads for the olive baboon dataset (GSE98965) were downloaded from
the European Nucleotide Archive (ENA). Sequencing reads were aligned to the human genome
(Homo_sapiens.GRCh38, Ensembl release 92), and the Papio anubis genome (Panu_3.0, Ensembl
release 93) respectively, using STAR aligner version 2.6.0a [71] with default parameters and the option
—quantMode TranscriptomeSAM. The TranscriptomeSAM option generates both a genome and a
transcriptome alignment by first aligning reads to the genome and then searching for concordance
between the genomic alignment and annotated transcripts. If a genomic alignment is mapped to several
transcriptomic coordinates, it is projected to all of them. The sample of the olive baboon amygdala
(AMY) taken at time point ZT 8 had a very low mapping rate (<1%) and was therefore excluded
from further analyses. Based on the STAR transcriptome alignment, transcript-level abundance was
quantified in units of transcripts per million (TPM) using Salmon version 0.10.2 [72] in alignment-based
mode with default parameters and the —seqBias option. Salmon considers all of the projected
alignment positions of a read and allocates it probabilistically by maximising the joint likelihood of
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all the observed data. The tximport R package version 1.6.0 [73] was used to import and scale the
resulting count tables by first multiplying TPM by feature length and then scaling up to the library size
(lengthScaledTPM) resulting in both transcript-level (txOut = TRUE, based on Ensembl Gene IDs) and
summarised gene-level (txOut = FALSE, based on Ensembl Transcript IDs) count estimates. For each
sample, normalisation factors to scale the raw library sizes were calculated using the trimmed mean of
M-values (TMM) method and counts were log2-transformed using the cpm function from the edgeR R
package version 3.20.9 [74]. For the baboon tissues, lowly expressed genes and transcripts were filtered
out, retaining only features with at least 0.5 counts per million (CPM) on average over all time points
per tissue. For the human CRC cell lines, all features with at least 0.5 CPM on average over all time
points in at least one of the two cell lines were retained. Counts were then renormalised using only the
selected features.
4.4. Rhythmicity Analysis
Rhythmicity analysis was performed on the absolute RMA-preprocessed transcript expression
values for the array data and on the transcript- and gene-level CPM values for the sequencing data.
12-h and 24-h rhythmicity was assessed using the RAIN R package version 1.12.0 [75]. Phase and relative
amplitude were determined by fitting a robust harmonic regression using the HarmonicRegression R
package version 1.91 [76] with a period of 12 h and 24 h, respectively. Circular mean and median of
peak phases were calculated with the R package circular (0.4-93) [77].
In the case of multiple transcript clusters annotated with the same Ensembl Gene ID in the array
data, only the transcript cluster with the lowest RAIN p-value per tissue was retained. For both the
array and the sequencing data, genes and transcripts with relative amplitude < 0.1 were excluded from
the set. The p-values of the remaining genes and transcripts of the sequencing data were FDR-corrected
using the Benjamini-Hochberg procedure. Significance for 12-h and 24-h rhythmic features was
bounded by q < 0.05 for the mouse array data sampled at 2-h intervals for 48 h, by p < 0.005 for
the baboon sequencing data sampled at 2-h intervals for 24 h and by p < 0.05 for the CRC cell line
sequencing data sampled at 3-h intervals for 30 h. Tissue-wise area-proportional Venn diagrams of the
logical relations between 12-h and 24-h rhythmic gene and transcript sets of the olive baboon were
visualised using the R package eulerr version 5.0.0 [78].
4.5. Compilation of a List of Splicing-Related Genes
A list of 426 human spliceosome and splicing-related genes was compiled by aggregating elements
from the following sources: 1) a list of 254 spliceosome components and splicing regulators from a
previous publication of our group [10], and 2) 404 splicing factor genes from a study by Seiler and
colleagues Seiler, Peng, Agrawal, Palacino, Teng, Zhu, Smith, Caesar-Johnson, Demchok and Felau [34].
Mapping these genes to their orthologues using Ensembl BioMart (Ensembl Genes 95) [79] resulted in
429 splicing-related genes for baboon and 451 splicing-related genes for mouse (Table S2).
4.6. Prediction of Clock Transcription Factor Binding Sites
Promoter sequences were extracted for the two sets of splicing-related genes detected to be 24-h
rhythmic in at least ten of the baboon tissues that showed an early and a late peak of expression,
respectively, and for a set of arrhythmic splicing-related genes. For each consistently 24-h rhythmic
splicing-related gene, all associated 24-h rhythmic transcripts were identified, while for the set of
arrhythmic splicing-related genes, the associated transcripts were filtered for those expressed in at least
one baboon tissue but not detected to be 24-h rhythmic (p > 0.05) in any tissue. Sequences of promoter
regions ± 1000 bp of the TSSs from Ensembl BioMart (Ensembl Genes 95) [79] were extracted using
bedtools [80]. Duplicate sequences were removed. The enrichment of four potential clock transcription
factor binding sites (D-box, E-box, E’-box, and RRE) in the promoter regions of the sets of early and
late-peaking splicing-related genes was tested using the Analysis of Motif Enrichment (AME) tool of
the MEME Suite version 4.12.0 [81] based on position-specific scoring matrices (PSSMs) [9], employing
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the average odds scoring method and one-tailed Fisher’s exact test with shuﬄed input sequences
as control.
4.7. Detection of Rhythmic AS in Circadian Whole-Transcript Microarray Data
Candidate genes with potential AS events in the murine microarray data were predicted using
the FIRMAGene method that was specifically developed for the Affymetrix Gene 1.0 ST platform and
that can be applied in the absence of replicates [23]. Using the RMA model, FIRMAGene decomposes
probe-level microarray data into probe effects and expression levels and calculates the departure
from the model through probe-wise residuals from the RMA fit. Based on the assumption that
several adjacent poorly fitting probes for the same exon region that behave differently from the rest
can be evidence of potential AS, the algorithm scores the persistence of residuals from the RMA
fit. Gene-level FIRMAGene scores were calculated for each time point using the FIRMAGene R
package version 0.9.8 in the Aroma platform as implemented in the aroma.affymetrix R package
version 3.1.1 [82] and a custom chip definition file (CDF) for MoGene (MoGene-1_0-st-v1,mm9.cdf,
http://bioinf.wehi.edu.au/folders/firmagene/). Relative amplitudes of the FIRMAGene scores were
determined by fitting a robust harmonic regression using the HarmonicRegression R package version
1.91 [76] with a period of 12 h and 24 h, respectively. Scores with relative amplitude < 0.1 were excluded.
The RAIN p-values of amplitude-filtered scores were FDR-corrected using the Benjamini-Hochberg
procedure and significance for 12-h and 24-h rhythmic FIRMAGene scores was bounded by q < 0.1.
Tissue-wise intersections between sets of genes with rhythmic FIRMAGene scores were visualised
using the UpSetR R package version 1.3.3 [83].
4.8. Detection of Differentially Rhythmic Splice Isoforms in Circadian RNA-seq Data
For the detection of differentially rhythmic isoforms in the RNA-seq data, the robustDODR
method from the DODR R package version 0.99.2 [26] was applied to calculate the p-value of differential
rhythmicity for each pair of rhythmic transcripts. For the baboon data, two rhythmic transcripts were
defined as a pair if they had the same gene identifier and the same period in the same tissue and if
one transcript had a RAIN p < 0.005 and the other a RAIN p < 0.05. For the CRC cell line data, all
transcripts pairs with a RAIN p < 0.05 were considered. The DODR p-values of the total number of
12-h and 24-h rhythmic isoforms pairs per tissue were FDR-corrected using the Benjamini-Hochberg
procedure and significance for differential rhythmicity was bounded by DODR q < 0.05. To specifically
identify isoforms with similar amplitudes and a strong phase difference, only differentially rhythmic
isoform pairs with a relative amplitude difference < 2 and a phase difference ≥ 2 h (for baboon tissues)
or ≥ 3 h (for human cell lines) for 12-h rhythmic transcripts and ≥ 4 h for 24-h rhythmic transcripts
(for both baboon and human cell lines) were retained for subsequent analyses.
4.9. Gene Enrichment Analysis
GO enrichment analysis (biological process—BP) of gene sets was performed using the
clusterProfiler R package version 3.10.1 [84]. For the sets of murine candidate genes with
rhythmic FIRMAGeneScores, org.Mm.eg.db version 3.7.0 was used for annotation and p-values
were FDR-corrected using the Benjamini-Hochberg procedure with significance bounded by q < 0.05.
The baboon candidate genes with differentially rhythmic phase-shifted isoform pairs were mapped to
orthologous human genes using Ensembl BioMart (Ensembl Genes 95). org.Hs.eg.db version 3.7.0
was used for annotation and p-values were FDR-corrected using the Benjamini-Hochberg procedure
with significance bounded by q < 0.05 for genes with 24-h rhythmic and with p < 0.05 for genes with
12-h rhythmic isoforms for baboon and by p < 0.05 for genes with 24-h rhythmic isoforms in SW480
and with q < 0.05 for genes with 24-h rhythmic isoforms in SW620 cells. For visualisation, GO terms
were manually curated to remove redundant categories. The complete lists of results can be found
in Table S4.
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